Susquehanna International Group
IHE icon

Susquehanna International Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Susquehanna International Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.24M Buy
60,401
+57,691
+2,129% +$5.05M ﹤0.01% 4141
2025
Q4 		$230K Sell
2,710
-12,123
-82% -$968K ﹤0.01% 10560
2025
Q3 		$1.08M Sell
14,833
-27,733
-65% -$1.91M ﹤0.01% 7189
2025
Q2 		$2.79M Sell
42,566
-5,517
-11% -$359K ﹤0.01% 5103
2025
Q1 		$3.39M Buy
48,083
+43,465
+941% +$3.02M ﹤0.01% 4395
2024
Q4 		$303K Sell
4,618
-43,667
-90% -$3M ﹤0.01% 9810
2024
Q3 		$3.41M Buy
48,285
+38,995
+420% +$2.72M ﹤0.01% 4315
2024
Q2 		$616K Sell
9,290
-36,108
-80% -$2.37M ﹤0.01% 7764
2024
Q1 		$3.08M Buy
+45,398
New +$3M ﹤0.01% 4465
2023
Q4 		– Sell
-61,959
Closed -$3.66M – 12787
2023
Q3 		$3.66M Sell
61,959
-75,924
-55% -$4.66M ﹤0.01% 4056
2023
Q2 		$8.23M Buy
137,883
+118,869
+625% +$7.07M ﹤0.01% 2769
2023
Q1 		$1.11M Sell
19,014
-91,617
-83% -$5.52M ﹤0.01% 6531
2022
Q4 		$6.86M Buy
110,631
+7,065
+7% +$425K ﹤0.01% 2767
2022
Q3 		$5.85M Buy
103,566
+67,359
+186% +$4.15M ﹤0.01% 2920
2022
Q2 		$2.31M Buy
36,207
+31,962
+753% +$2.03M ﹤0.01% 4607
2022
Q1 		$275K Sell
4,245
-1,269
-23% -$80.4K ﹤0.01% 10483
2021
Q4 		$367K Sell
5,514
-5,604
-50% -$355K ﹤0.01% 9998
2021
Q3 		$679K Sell
11,118
-3,585
-24% -$228K ﹤0.01% 8607
2021
Q2 		$910K Sell
14,703
-59,373
-80% -$3.61M ﹤0.01% 8025
2021
Q1 		$4.39M Buy
74,076
+48,939
+195% +$2.95M ﹤0.01% 4168
2020
Q4 		$1.5M Sell
25,137
-113,826
-82% -$6.49M ﹤0.01% 5737
2020
Q3 		$7.58M Buy
138,963
+19,944
+17% +$1.08M ﹤0.01% 2541
2020
Q2 		$6.11M Buy
119,019
+47,391
+66% +$2.38M ﹤0.01% 2735
2020
Q1 		$3.21M Buy
71,628
+60,483
+543% +$3.05M ﹤0.01% 3179
2019
Q4 		$595K Sell
11,145
-48,213
-81% -$2.38M ﹤0.01% 6606
2019
Q3 		$2.77M Sell
59,358
-11,532
-16% -$552K ﹤0.01% 3620
2019
Q2 		$3.56M Sell
70,890
-25,332
-26% -$1.25M ﹤0.01% 3186
2019
Q1 		$4.94M Buy
96,222
+87,861
+1,051% +$4.37M ﹤0.01% 2479
2018
Q4 		$392K Buy
8,361
+3,921
+88% +$201K ﹤0.01% 6495
2018
Q3 		$248K Sell
4,440
-102,375
-96% -$5.59M ﹤0.01% 7837
2018
Q2 		$5.39M Buy
106,815
+49,884
+88% +$2.47M ﹤0.01% 2618
2018
Q1 		$2.8M Buy
56,931
+5,943
+12% +$305K ﹤0.01% 3357
2017
Q4 		$2.62M Sell
50,988
-56,337
-52% -$2.89M ﹤0.01% 3453
2017
Q3 		$5.59M Buy
107,325
+88,182
+461% +$4.53M ﹤0.01% 2363
2017
Q2 		$990K Sell
19,143
-13,989
-42% -$707K ﹤0.01% 5285
2017
Q1 		$1.67M Buy
33,132
+20,124
+155% +$996K ﹤0.01% 4062
2016
Q4 		$613K Sell
13,008
-36,045
-73% -$1.71M ﹤0.01% 6559
2016
Q3 		$2.44M Buy
49,053
+15,687
+47% +$796K ﹤0.01% 3232
2016
Q2 		$1.61M Sell
33,366
-84,579
-72% -$4.02M ﹤0.01% 3959
2016
Q1 		$5.38M Buy
117,945
+109,677
+1,327% +$5.13M ﹤0.01% 2213
2015
Q4 		$445K Sell
8,268
-138,429
-94% -$7.28M ﹤0.01% 6996
2015
Q3 		$7.24M Buy
146,697
+101,160
+222% +$5.8M ﹤0.01% 2190
2015
Q2 		$2.65M Buy
+45,537
New +$2.66M ﹤0.01% 4101
2015
Q1 		– Sell
-131,337
Closed -$6.62M – 9632
2014
Q4 		$6.62M Buy
131,337
+9,180
+8% +$447K ﹤0.01% 2487
2014
Q3 		$5.71M Buy
122,157
+74,028
+154% +$3.34M ﹤0.01% 2826
2014
Q2 		$2.17M Sell
48,129
-4,353
-8% -$187K ﹤0.01% 4512
2014
Q1 		$2.22M Sell
52,482
-29,451
-36% -$1.23M ﹤0.01% 4164
2013
Q4 		$3.23M Buy
81,933
+46,932
+134% +$1.76M ﹤0.01% 3550
2013
Q3 		$1.24M Sell
35,001
-77,247
-69% -$2.72M ﹤0.01% 4922
2013
Q2 		$3.73M Buy
+112,248
New +$3.73M ﹤0.01% 3008

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Susquehanna International Group's IHE Position: Q1 2026 in Review

Susquehanna International Group increased its iShares US Pharmaceuticals ETF (IHE) stake by 2,129% in Q1 2026, buying an estimated $5.05M and bringing the position to 60,401 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

Susquehanna International Group first reported a position in IHE in Q2 2013 and has held it in 50 quarters since. The position peaked at $8.23M in Q2 2023. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Susquehanna International Group held 60,401 shares of iShares US Pharmaceuticals ETF worth $5.24M as of Q1 2026.
  • Susquehanna International Group bought 57,691 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $5.05M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4141 holding.
  • Susquehanna International Group first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's iShares US Pharmaceuticals ETF position peaked at $8.23M in Q2 2023.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.